Boostagen Dosage/Direction for Use

A single 0.5 mL dose of Boostagen is recommended. Boostagen should be given in accordance with WHO and national recommendations or medical practices for booster vaccination and for maternal immunization: in the second or third trimester and preferably at least 15 days before the end of pregnancy; in adolescents and adults with an unknown or incomplete immunization against diphtheria or tetanus as part of vaccination program; for tetanus prophylaxis in wound management. Tetanus immunoglobulin should be administered in accordance with existing recommendations.
Mode of Administration: Shake the syringe well to obtain a uniform, cloudy and white suspension. Do not use if resuspension does not occur after vigorous shaking.
Boostagen should be administered by deep intramuscular injection, preferably in the deltoid region. Before injection, the skin over the site of injection should be cleaned with a suitable germicide. Open the needle cap of the pre-filled syringe, administer the total volume of 0.5 mL intramuscularly (IM).